This study evaluated relationships between glycaemic control, body mass index (BMI), comorbidities and pharmacological treatment in patients with type 2 diabetes mellitus (T2D).This was a retrospective, cross-sectional analysis of Quintiles electronic medical records research data (study period 1 October 2013-30 September 2014). Eligibility included age ≥18 years, T2D diagnosis, and at least one available BMI measurement.The study included 626 386 patients (mean age, 63.8 year; 51.3
作者：Wayne, Weng；Ye, Tian；Edward S, Kimball；Sheldon X, Kong；Jonathan, Bouchard；Todd M, Hobbs；Brian, Sakurada
来源：BMJ open diabetes research & care 2017 年 5卷 1期
